FTL antibody (Middle Region)

Catalog No. ABIN631142

The Rabbit Polyclonal anti-FTL antibody has been validated for WB. It is suitable to detect FTL in samples from Human and Rat.

Quick Overview for FTL antibody (Middle Region) (ABIN631142)

Target: FTL (Ferritin, Light Polypeptide (FTL))

Reactivity: Human, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FTL antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-FTL Antibody

Binding Specificity: Middle Region

Specificity: FTL antibody was raised against the middle region of FTL

Purification: Affinity purified

Immunogen: FTL antibody was raised using the middle region of FTL corresponding to a region with amino acids ALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPE

Application Details

Application Notes: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

FTL Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this FTL antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FTL antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for FTL

Target: FTL (Ferritin, Light Polypeptide (FTL))

Alternative Name: FTL

Background: FTL is the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. Defects in this light chain ferritin gene are associated with several neurodegenerative diseases and hyperferritinemia-cataract syndrome.

Molecular Weight: 20 kDa (MW of target protein)

Pathways: Transition Metal Ion Homeostasis